{
  "id": 5569,
  "url": "https://nnemf.org/research/5569-evaluation-of-the-effects-of-extremely-low-frequency",
  "title": "Evaluation of the effects of extremely low frequency electromagnetic field on the levels of some inflammatory cytokines in post-stroke patients.",
  "authors": [
    "Natalia Cichon",
    "Joanna Saluk-Bijak",
    "Elzbieta Miller",
    "Tomasz Sliwinski",
    "Ewelina Synowiec",
    "Paulina Wigner",
    "Michal Bijak"
  ],
  "journal": "Journal of rehabilitation medicine",
  "year": "2019",
  "doi": "10.2340/16501977-2623",
  "pmid": "31690951",
  "abstract": "BACKGROUND: Activation of immunologically competent cells results in the overproduction of pro-inflammatory factors, and causes progression of nerve tissue damage. However, the potential neuroprotective effects of these factors in brain damage have not been well investigated. OBJECTIVE: To evaluate the effect of extremely low frequency electromagnetic field (ELF-EMF) treatment on the molecular mechanism of inflammatory cytokine activity in post-stroke patients. METHODS: All patients underwent the same rehabilitation program, but the ELF-EMF group were also given ELF-EMF treatment. Both groups have been used in our previous studies. In order to determine the plasma level of cytokines, the levels of interleukin 1β (IL-1β), interleukin 2 (IL-2), interferon-γ (INF-γ) and transforming growth factor β (TGF-β) were evaluated, and the level of IL-1β mRNA expression was determined. RESULTS: After ELF-EMF treatment, both IL-1β plasma level and IL-1β mRNA expression level, as well as IL-2 plasma level increased, while IFN-γ and TGF-β levels did not change. CONCLUSION: The increased expression of IL-1β found in this study may be a response to ELF-EMF stimulation. It is hypothesized that a neuroprotective role of this cytokine may occur due to IL-1β-dependent regulation of neurotrophic factors. Further research is needed to explore this hypothesis.",
  "effect": "mixed",
  "evidence": "insufficient",
  "extraction": {
    "studyType": "unknown",
    "studyTypeLabel": "Unknown",
    "effectDirection": "mixed",
    "evidenceLabel": "Insufficient",
    "population": "Post-stroke patients",
    "sampleSize": "—",
    "exposure": "ELF <1 MHz",
    "confidencePct": "66",
    "peerReviewed": "yes",
    "mainFindings": "After ELF-EMF treatment, IL-1β plasma level and IL-1β mRNA expression increased, and IL-2 plasma level increased; IFN-γ and TGF-β levels did not change.",
    "outcomes": [
      "Plasma IL-1β level",
      "IL-1β mRNA expression level",
      "Plasma IL-2 level",
      "Plasma IFN-γ level",
      "Plasma TGF-β level"
    ],
    "limitations": [
      "Study design and randomization/blinding not described in the abstract",
      "Sample size not reported",
      "ELF-EMF exposure parameters (frequency",
      "intensity",
      "duration) not reported",
      "Both groups were used in previous studies (details not provided here)"
    ],
    "keywords": [
      "extremely low frequency",
      "ELF-EMF",
      "stroke",
      "post-stroke",
      "rehabilitation",
      "cytokines",
      "inflammation",
      "IL-1β",
      "IL-2",
      "IFN-γ",
      "TGF-β",
      "mRNA expression"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"unknown\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": \"therapeutic/rehabilitation treatment\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Post-stroke patients\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Plasma IL-1β level\",\n    \"IL-1β mRNA expression level\",\n    \"Plasma IL-2 level\",\n    \"Plasma IFN-γ level\",\n    \"Plasma TGF-β level\"\n  ],\n  \"main_findings\": \"After ELF-EMF treatment, IL-1β plasma level and IL-1β mRNA expression increased, and IL-2 plasma level increased; IFN-γ and TGF-β levels did not change.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"Study design and randomization/blinding not described in the abstract\",\n    \"Sample size not reported\",\n    \"ELF-EMF exposure parameters (frequency, intensity, duration) not reported\",\n    \"Both groups were used in previous studies (details not provided here)\"\n  ],\n  \"evidence_strength\": \"insufficient\",\n  \"confidence\": 0.66,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"extremely low frequency\",\n    \"ELF-EMF\",\n    \"stroke\",\n    \"post-stroke\",\n    \"rehabilitation\",\n    \"cytokines\",\n    \"inflammation\",\n    \"IL-1β\",\n    \"IL-2\",\n    \"IFN-γ\",\n    \"TGF-β\",\n    \"mRNA expression\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/31690951/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5569",
  "updated": "2026-02-14 08:47:31"
}